Search: id:"swepub:oai:gup.ub.gu.se/181379" >
Baseline patient ch...
Baseline patient characteristics associated with placebo remission and their impact on remission with duloxetine and selected SSRI antidepressants.
-
Nelson, J Craig (author)
-
Zhang, Qianyi (author)
-
Kelin, Katarina (author)
-
show more...
-
- Eriksson, Elias, 1956 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi,Institute of Neuroscience and Physiology, Department of Pharmacology
-
Deberdt, Walter (author)
-
Berk, Michael (author)
-
show less...
-
(creator_code:org_t)
- 2013-04-25
- 2013
- English.
-
In: Current medical research and opinion. - : Informa Healthcare. - 1473-4877 .- 0300-7995. ; 29:7, s. 827-33
- Related links:
-
https://gup.ub.gu.se...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- We examined whether identification of patients with placebo-remitter characteristics and placebo-nonremitter characteristics enhances the ability to identify drug-placebo treatment differences and, perhaps, differences between agents in major depressive disorder (MDD). We hypothesized: 1) that drug-placebo differences in remission rates would be greater for both duloxetine and selective serotonin reuptake inhibitors (SSRIs) among placebo nonremitters than placebo remitters and: 2) that the difference between active treatments would also be greater in placebo nonremitters than placebo remitters.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Keyword
- Baseline
- duloxetine
- SSRI antidepressants
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database